Anemia, Refractory - 25 Studies Found

Completed : Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia
:
  • Blastic Phase Chronic Myelogenous Leukemia
  • Recurrent Adult Acute Lymphoblastic Leukemia

    • : 2006-01-16
    :
    • Drug: alvocidib Given by infus
Completed : Bowel Preparation and Prokinetics in Capsule Endoscopy
:
  • Small Bowel Disease
  • Gastrointestinal Hemorrhage
  • : 2006-01-10
    :
    • Drug: Senna
    • Drug: Citramag powder
Completed : Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
:
  • Acute Lymphoid Leukemia
  • Acute Myeloid Leukemia
  • : 2011-10-24
    :
    • Drug: brentuximab vedotin 1.8

Completed : Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies
:
  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Mye
    : 2002-05-24
    : Drug: Hum-195/rGel Starting Dose = 3 mg/m^2 twice weekly for 2 weeks.
Completed : Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T
:
  • De Novo Akute Myeloid Leukemia (AML)
  • Secondary Acute Myeloid Leukemia (AML)
  • Drug: Cytarabine
  • Drug: Idarubicin
Terminated : Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
:
  • Acute Myeloid Leukemia (AML)
  • Acute Promyelocytic Leukemia (APL)
  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Mye
    : 2008-12-15
    : Biological: GM-K562/leukemia cell vaccine Cultured cell line genetically changed to secrete GM-CSF mixed
Recruiting : Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
:
  • Myelodysplastic Syndrome
  • MDS
  • Refract
    : 2015-09-25
    :
    • Drug: rigosertib Patients will
Active, not recruiting : Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
:
  • Myelodysplastic Syndromes
  • Refractory Anemia With Excess Blasts<
    : 2013-08-21
    : Drug: rigosertib sodium Other Names:
    • ON 01910.Na
    • SyB L-1101
Completed : Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
:
  • Chronic Myelomonocytic Leukemia
  • Previously Treated Myelodysplastic Syndromes
  • : 2000-07-05
    :
    • Drug: liposomal daunorubicin citrate

Next >>>